Pfizer and BioNTech win bid to invalidate CureVac’s COVID vaccine patents in UK

Pfizer and its partner BioNTech won their bid to invalidate CureVac’s COVID vaccine patents in the High Court in London. Pfizer and BioNTech had filed their lawsuit in September 2022 over patents related to messenger RNA technology.

Teile diesen Beitrag:

BELIEBTE BEITRÄGE
FOLGEN SIE UNS
Like uns auf Facebook
Folge uns auf Twitter
Abonniere unseren Kanal
Tick Tack
LIVEÜBERTRAGUNG